ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 717 out of 3647

$4.6M Total Retail Price of All Prescriptions

Rank: 5 out of 3647

232 Patients Receiving at Least One Drug in Part D
14%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 232 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 1,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$401 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NORVIR 983 137 10 1 154
ISENTRESS 671 109 10 2 189
CRESTOR 566 96 3 19
TRUVADA 564 43 4 158
REYATAZ 524 102 10 5 225
PREZISTA 426 38 6 204
ATRIPLA 352 12 7 257
OMEPRAZOLE 219 16 8 3
INTELENCE 203 46 9 287
TRAMADOL HCL 195 22 10 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 194 17 11 110
IBUPROFEN 188 27 12 55
PROAIR HFA 185 23 13 62
LISINOPRIL 181 61 14 4
NASONEX 180 28 15 220
NEXIUM 159 0 16 44
EPZICOM 154 59 17 260
ENALAPRIL MALEATE 154 17 17 35
FLUCONAZOLE 144 0 19 226
CYCLOBENZAPRINE HCL 141 27 R 20 98
DRONABINOL 141 0 10 20 350
METFORMIN HCL 139 35 22 6
ACYCLOVIR 123 0 23 259
CLOTRIMAZOLE-BETAMETHASONE 114 16 24 84
AMLODIPINE BESYLATE 106 14 25 2
TRAZODONE HCL 102 35 26 64
GABAPENTIN 98 12 27 17
POTASSIUM CHLORIDE 93 20 28 24
HYDROCHLOROTHIAZIDE 91 20 29 9
TRICOR 89 0 30 144
NAPROXEN 88 17 31 70
LOPERAMIDE 76 0 32 271
LEVOTHYROXINE SODIUM 76 0 32 5
FUROSEMIDE 76 27 32 8
SUSTIVA 74 13 35 420
PROMETHAZINE HCL 70 16 R 36 182
RANITIDINE HCL 69 0 37 29
LOSARTAN POTASSIUM 65 13 38 11
AZITHROMYCIN 63 0 39 34
TRIAMCINOLONE ACETONIDE 63 16 39 136
GLIPIZIDE 61 16 41 41
FLUOXETINE HCL 61 0 41 68
LYRICA 60 40 43 120
METOPROLOL TARTRATE 55 15 44 7
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.